Vaxcyte Inc (PCVX)

Vaxcyte Inc (PCVX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $9.5B; returns 1 day -3.9%, 1 week -5.0%, 1 year +45.3%.

Vaxcyte, Inc. (PCVX) is a clinical-stage vaccine innovation company focused on developing a new generation of broad-spectrum conjugate and novel protein vaccines to prevent or treat serious bacterial infectious diseases.

Groups PCVX belongs to

• Biotechnology
• Clinical Stage Biotech
• Healthcare
• Infectious Diseases
• Life Sciences
• Biologics
• Clinical Stage
• R&D
• Fast Track Designation

PCVX financial model: income statement, cash flow and balance sheet